IRIS publication 380506
Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease.
RIS format for Endnote and similar
TY - CONF - Harris, D.M., Fisher, A., Harkin, A.J., Bolton,A.E., Sullivan, A.M., Nolan, Y.M. - Royal Irish Academy of Medicine - Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease. - Dublin, Ireland - Poster Presentation - 2005 - () - 0 - 05-JAN-05 - 06-JAN-05 DA - 2005/NaN ER -
BIBTeX format for JabRef and similar
@unpublished{V380506, = {Harris, D.M. and Fisher, A. and Harkin, A.J. and Bolton, A.E. and Sullivan, A.M. and Nolan, Y.M. }, = {Royal Irish Academy of Medicine}, = {{Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease.}}, = {Dublin, Ireland}, = {Poster Presentation}, = {2005}, = {()}, = {0}, month = {Jan}, = {06-JAN-05}, source = {IRIS} }
Data as stored in IRIS
AUTHORS | Harris, D.M., Fisher, A., Harkin, A.J., Bolton,A.E., Sullivan, A.M., Nolan, Y.M. | ||
TITLE | Royal Irish Academy of Medicine | ||
PUBLICATION_NAME | Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease. | ||
LOCATION | Dublin, Ireland | ||
CONFERENCE_TYPE | Poster Presentation | ||
YEAR | 2005 | ||
TIMES_CITED | () | ||
PEER_REVIEW | 0 | ||
START_DATE | 05-JAN-05 | ||
END_DATE | 06-JAN-05 | ||
ABSTRACT | |||
FUNDED_BY | * |